SEMPREX 4 mg/5 ml, solution buvable
Country: France
Language: French
Source: ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
acrivastine
Available from:
Laboratoire GLAXOSMITHKLINE
INN (International Name):
acrivastine
Dosage:
0,080 g
Pharmaceutical form:
solution
Composition:
composition pour 100 ml > acrivastine : 0,080 g
Administration route:
orale
Units in package:
1 flacon(s) en verre brun de 100 ml
Product summary:
331 100-2 ou 34009 331 100 2 4 - 1 flacon(s) en verre brun de 100 ml - Déclaration de commercialisation non communiquée:;
Authorization status:
Abrogée
Authorization date:
1989-08-29
